Table 1

Results of investigations in relation to clinical presentation, attendance and vaccination

Timeline
T0T1*T11†T16‡T20§
First attendanceVaccine dose 1Vaccine dose 2Second attendanceThird attendance
Symptoms and signsRectal pain, rectal discharge and inguinal lymphadenopathyHeadache, back pain, neck pain, anal sore and apthous mouth ulcerRectal pain, rectal discharge
Investigations (sites)
CT/GC NAAT (Aptima Combo, Hologic) (rectal and pharyngeal swabs, urine)NegativeNegativeGC positive (rectal)
HSV PCR (in-house lab based test at UKHSA, Bristol) (rectal, etc)HSV-2 positive (rectal)Negative (anal sore)
Negative (mouth ulcer)
Not tested
T.pallidum PCR (in-house lab based test at UKHSA, Colindale) (rectal etc))Negative (rectal)Negative (anal sore)
Negative (ulcer in mouth)
Negative (rectal)
Orthopoxvirus DNA PCR and mpox virus PCR (UKHSA lab developed test) (rectal, etc)Positive (rectal)Positive (anal sore)
Negative (ulcer in mouth)
Negative (rectal)
HIV (Architect HIV Ag/Ab combo assay (Abbott)) (serum)NegativeNegativeNegative
Hepatitis C (Architect anti-HCV assay (Abbott)) (serum)NegativeNegativeNegative
RPR (rapid plasma reagin) (serum)1:2Positive neatPositive neat
  • *1 week after first attendance.

  • †11 weeks after first attendance.

  • ‡16 weeks after first attendance.

  • §4 weeks after second attendance.

  • CT, Chlamydia trachomatis; GC, Neisseria gonorrhoeae; HSV, herpes simplex virus; mpox, monkeypox.